FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

Compounding facility ProRx Pharmacy Network has received an FDA warning letter over issues with its semaglutide and ...

In SURMOUNT-1, people taking 15 mg of tirzepatide lost on average 22.5% ... the label outlined usage for adults with obesity (a BMI of ≥30) or overweight (BMI 27 to <30) with the presence ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and weight-loss tirzepatide ... pens (2.5 mg/0.5 mL, 5 ...

The 72‑week treatment period included a dose-escalation phase. Tirzepatide was started at a dose of 2.5 mg once weekly (or matching placebo) and the dose was increased by 2.5 mg every 4 weeks until ...

The FDA is about to make it a lot harder to get cheap weight-loss drugs Jessica DeBenedetto has only been on compounded tirzepatide for a couple of weeks, but she already feels like it's a life ...

Higher doses of tirzepatide were particularly effective, with mean fasting insulin percent reductions of 27.76% (P =.003; 10 mg dose) and 37.0% (P <.00001; 15 mg dose) compared with placebo. All doses ...

The mean baseline blood glucose levels (expressed in mg/dL) were 88.2±9.0 for oral DehydraTECH-tirzepatide and 87.8±11.3 for injected Zepbound®, compared to the Study-ending levels of 83.2±5.7 ...